Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review

被引:90
|
作者
Lahousse, Lies [1 ,2 ]
Tiemeier, Henning [2 ,3 ]
Ikram, M. Arfan [2 ,4 ,5 ]
Brusselle, Guy G. [1 ,2 ,6 ]
机构
[1] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium
[2] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands
[3] Erasmus MC, Dept Psychiat, NL-3000 CA Rotterdam, Netherlands
[4] Erasmus MC, Dept Radiol, NL-3000 CA Rotterdam, Netherlands
[5] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands
[6] Erasmus MC, Dept Resp Med, NL-3000 CA Rotterdam, Netherlands
关键词
Chronic obstructive pulmonary disease; Stroke; Cerebrovascular disease; Cerebral small vessel disease; Cognitive impairment; MILD COGNITIVE IMPAIRMENT; SMALL VESSEL DISEASE; LUNG-FUNCTION; CEREBRAL MICROBLEEDS; ISCHEMIC-STROKE; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; VASCULAR DEPRESSION; SMOKING; COPD;
D O I
10.1016/j.rmed.2015.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Along with the aging population, the public health burden of cerebrovascular disease is increasing. Cerebral small vessel disease and accumulation of brain pathology associate with cognitive decline and can lead to clinical outcomes, such as stroke and dementia. Chronic Obstructive Pulmonary Disease (COPD) is a common respiratory disease among elderly. The quality of life and prognosis of patients with COPD is greatly determined by the presence of comorbidities including stroke and cognitive impairment. Despite the clinical relevance of cerebral small vessel disease, stroke and (vascular) cognitive impairment in patients with COPD, literature is scarce and underlying mechanisms are unknown. The aim of the present review is therefore to summarize current scientific knowledge, to provide a better understanding of the interplay between COPD and the aging brain and to define remaining knowledge gaps. This narrative review article 1) overviews the epidemiology of cerebral small vessel disease, stroke and cognitive impairment in patients with COPD; 2) discusses potential underlying mechanisms including aging, smoking, systemic inflammation, vasculopathy, hypoxia and genetic susceptibility; and 3) highlights areas requiring further research. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1371 / 1380
页数:10
相关论文
共 50 条
  • [41] Chronic Obstructive Pulmonary Disease
    Whittaker, Catherine
    [J]. SA PHARMACEUTICAL JOURNAL, 2010, 77 (07) : 32 - 36
  • [42] Chronic obstructive pulmonary disease
    Peter J. Barnes
    Peter G. J. Burney
    Edwin K. Silverman
    Bartolome R. Celli
    Jørgen Vestbo
    Jadwiga A. Wedzicha
    Emiel F. M. Wouters
    [J]. Nature Reviews Disease Primers, 1
  • [43] Chronic obstructive pulmonary disease
    Bourbeau, Jean
    Gagnon, Sebastien
    Ross, Bryan
    [J]. CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2020, 4 : S28 - S33
  • [44] Chronic obstructive pulmonary disease
    Roche, N
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2004, 21 : S22 - S33
  • [46] Chronic obstructive pulmonary disease
    Hodson, Richard
    [J]. NATURE, 2020, 581 (7807) : S1 - S1
  • [47] Chronic obstructive pulmonary disease
    Kerstjens, HA
    Postma, DS
    [J]. AMERICAN FAMILY PHYSICIAN, 2002, 66 (05) : 845 - 846
  • [48] Chronic obstructive pulmonary disease
    Shmelev, EI
    [J]. TERAPEVTICHESKII ARKHIV, 1999, 71 (12): : 74 - 78
  • [49] CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Brody, Herb
    [J]. NATURE, 2012, 489 (7417) : S1 - S1
  • [50] Chronic obstructive pulmonary disease
    Penz, Erika
    Stickland, Michael K.
    Walker, Brandie
    [J]. CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2021, 5 (02) : 84 - 88